Desjardins Global Asset Management’s Pfizer PFE Stock Holding History

Desjardins Global Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$1.06M	Sell	36,750 -13,744	-27%	-$415K	0.11%	174
2023 Q3	$1.67M	Buy	50,494 +884	+2%	+$31.3K	0.18%	130
2023 Q2	$1.82M	Buy	49,610 +2,401	+5%	+$93.5K	0.21%	112
2023 Q1	$1.93M	Buy	47,209 +22,252	+89%	+$961K	0.24%	90
2022 Q4	$1.28M	Sell	24,957 -36,103	-59%	-$1.73M	0.2%	110
2022 Q3	$2.67M	Buy	61,060 +7,045	+13%	+$342K	0.34%	54
2022 Q2	$2.83M	Sell	54,015 -110,578	-67%	-$5.63M	0.37%	59
2022 Q1	$8.52M	Buy	164,593 +41,071	+33%	+$2.13M	0.74%	20
2021 Q4	$7.29M	Buy	+123,522	New	+$6.12M	0.62%	29

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Desjardins Global Asset Management's PFE Position: Q4 2023 in Review

Desjardins Global Asset Management reduced its Pfizer (PFE) stake by 27% in Q4 2023, selling an estimated $415K and leaving 36,750 shares worth $1.06M. The position accounts for 0.11% of the portfolio, ranked #174.

Desjardins Global Asset Management first reported a position in PFE in Q4 2021 and has held it in 9 quarters since. The position peaked at $8.52M in Q1 2022. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

Desjardins Global Asset Management held 36,750 shares of Pfizer worth $1.06M as of Q4 2023.
Desjardins Global Asset Management sold 13,744 Pfizer shares in Q4 2023, an estimated $415K.
Pfizer made up 0.11% of Desjardins Global Asset Management's portfolio in Q4 2023, its #174 holding.
Desjardins Global Asset Management first reported a position in Pfizer in Q4 2021 and has held it in 9 quarters since.
Desjardins Global Asset Management's Pfizer position peaked at $8.52M in Q1 2022.
2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on Desjardins Global Asset Management's 13F filing for Q4 2023, filed 30 Jan 2024.